| Description | The antibody is produced by Epstein-Barr virus transformation of Pneumovax recipient peripheral lymphocytes. The mAb prolongs the survival of normal and C4-deficient mice infected with lethal serotype 8 S. pneumoniae in vivo. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Streptococcus pneumoniae |
| Isotype | IgM, kappa |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; WB; Neut |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | S. pneumoniae |
| Alternative Name | Streptococcus pneumoniae; pneumococcus |
| Research Area | Microbiology |
